Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Organon & Co. (OGN) Profit Margins

Over the twelve months to 2026-06-30, Organon & Co. (OGN) had gross margin 52.7%, net margin 3.4%, free cash flow margin 9.3%, according to EquiReason's reading of its SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

OGNOrganon & Co.Follow OGN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
3.6B
P/E TTM
17.6
Dividend yield
0.6%
52-week
—
Next earnings
9 Nov, in 16 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
TTM
Jun 26
Trend
Gross margin62.2%62.8%59.8%58.0%53.3%52.7%
Net margin21.4%14.9%16.3%13.5%3.0%3.4%
FCF margin31.2%10.7%8.7%11.9%8.7%9.3%

USD billions · SEC XBRL

Organon & Co. — questions

What is Organon & Co.'s gross margin?
52.7% over the twelve months to 2026-06-30.
What is Organon & Co.'s net profit margin?
3.4% over the twelve months to 2026-06-30.

Every figure on this page comes from Organon & Co.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.